Campbell, United States
Ostial Corp is a pioneering company in the health care and manufacturing sectors, distinguished by its innovative product, the FLASH™ Aorto-Ostial Angioplasty System. This unique system is heralded as the first and only dual-balloon catheter designed for TRUE 360° stent apposition, addressing both coronary and peripheral ostial cases with its innovative 2-in-1 design.
Founded in 2010 and based in the United States, Ostial Corp aims to redefine angioplasty procedures, emphasizing comprehensive lesion coverage. Their commitment to revolutionizing medical procedures aligns with the growing demand for advanced health care solutions, making them a compelling candidate for investment in cutting-edge medical technologies.
The company's growth trajectory received a strong endorsement through a $7.50M Series C investment on 16 September 2022, supported by top-tier investors, Delos Capital and AMED Ventures. This investment underscores confidence in Ostial Corp's capabilities and future market potential.
